Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 2

1(16.7%)

6Total

N/A(5)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06769451Not ApplicableNot Yet Recruiting

Proton Radiosurgery for the Treatment of Malignant Ventricular Tachyarrhythmias

Role: lead

NCT05991596Not ApplicableCompleted

Vitiligo and Psychodrama Therapy

Role: lead

NCT05629221Not ApplicableUnknown

Organisational Models Supported by Technology for the Management of Diabetic Disease and Its Complications in a Diabetic Clinic Setting. A Randomised Controlled Trial Targeting Type 2 Diabetes Individuals With Non-ideal Glycemic Values

Role: lead

NCT05863065Not ApplicableCompleted

Personalized Virtual Reality Naturalistic Scenarios in Cognitive Impairment

Role: collaborator

NCT02067026Not ApplicableCompleted

Measuring the Impact of Dietary Supplementation With a High Fiber, High Antioxidant Aleurone on Biomarkers of Cardiovascular Disease and Gut Microbiota in Adults With High Body Mass Index

Role: collaborator

NCT01784549Phase 2Unknown

Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)Disease

Role: collaborator

All 6 trials loaded